A detailed history of Alcosta Capital Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Alcosta Capital Management, Inc. holds 30,176 shares of NVO stock, worth $3.1 Million. This represents 2.15% of its overall portfolio holdings.

Number of Shares
30,176
Previous 29,959 0.72%
Holding current value
$3.1 Million
Previous $4.28 Million 15.97%
% of portfolio
2.15%
Previous 2.63%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $25,838 - $31,556
217 Added 0.72%
30,176 $3.59 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $21,106 - $25,268
-172 Reduced 0.57%
29,959 $4.28 Million
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $10,313 - $13,727
-101 Reduced 0.33%
30,131 $3.87 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $2.65 Million - $3.19 Million
30,232 New
30,232 $3.13 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Alcosta Capital Management, Inc. Portfolio

Follow Alcosta Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alcosta Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alcosta Capital Management, Inc. with notifications on news.